NP213
NP213 is a rapidly acting, novel, first-in-class synthetic antimicrobial peptide (AMP), has anti-fungal activities. NP213 targets the fungal cytoplasmic membrane and plays it role via membrane perturbation and disruption. NP213 is effective and well-tolerated in resolving nail fungal infections[1][2].
Product Specifications
CAS Number
942577-31-3
UNSPSC
12352209
Hazard Statement
H302-H315-H319
Target
Fungal
Type
Peptides
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/np213.html
Solubility
10 mM in DMSO
Smiles
N=C(N)NCCC[C@H](NC([C@@H](NC([C@@H](NC([C@@H](N1)CCCNC(N)=N)=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O)C(N[C@H](C(N[C@H](C(N[C@H](C1=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O
Molecular Formula
C42H84N28O7
Molecular Weight
1093.30
Precautions
P264-P270-P280-P302+P352-P305+P351+P338-P330-P362+P364-P501
References & Citations
[1]Mercer DK, et al. Improved Methods for Assessing Therapeutic Potential of Antifungal Agents against Dermatophytes and Their Application in the Development of NP213, a Novel Onychomycosis Therapy Candidate.Antimicrob Agents Chemother. 2019 Apr 25;63 (5) . pii: e02117-18|[2]Neelabh, et al. Sequential and Structural Aspects of Antifungal Peptides from Animals, Bacteria and Fungi Based on Bioinformatics Tools.Probiotics Antimicrob Proteins. 2016 Jun;8 (2) :85-101.|[3]Novamycin®/NP339 Technology Summary
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LS002159 100 µg
Factor X (F10) (NM_000504) Human Over-expression Lysate
Sign In for Pricing
View Details 
GTR15099587 1 Vial
Lentiviral human CYP7B1 shRNA (UAS) - Lentiviral human CYP7B1 shRNA (UAS, RFP) (25)
Sign In for Pricing
View Details 